Q4FY25 Earning Calendar: AUROPHARMA, FIRSTCRY, GICRE, GILLETTE, KEC, PTC, SHILPAMED, VADILALIND, VADILENT, VENUSPIPES
MUMBAI, 26 MAY:
| 26-05-2025: | ACE, AKUMS, AUROPHARMA, AWFIS, AXISCADES, BAJAJHCARE, BALAMINES, BAYERCROP, BLUEDART, CAPACITE, CROPSTER, FIRSTCRY, GICRE, GILLETTE, GOLDIAM, GRAUWEIL, HITECH, INA, INFIBEAM, IPL, JINDRILL, JITFINFRA, KEC, LAXMIDENTL, LUMAXIND, MAHSEAMLES, MONTECARLO, NAZARA, OLECTRA, OPTIEMUS, ORCHPHARMA, PANAMAPET, PARKHOTELS, PDMJEPAPER, PILANIINVS, PTC, RATEGAIN, SAKSOFT, SANATHAN, SCHNEIDER, SHILPAMED, STANLEY, STYLAMIND, SUMICHEM, TALBROAUTO, TIL, VADILALIND, VADILENT, VENUSPIPES, WINDMACHIN, YATHARTH |
AUROPHARMA YoY
Revenue expected at Rs 8266 crore versus Rs 7580 crore
EBITDA expected to be seen at Rs 1819 crore versus Rs 1672 crore
EBITDA margin expected to be seen at 22.00% versus 22.07%
Net profit expected to be seen at Rs 1022 crore versus Rs 1030 crore
FIRSTCRY QoQ
Revenue expected at Rs 1913 crore versus Rs 2172 crore
EBITDA expected to be seen at Rs 20 crore versus Rs 152 crore
EBITDA margin expected to be seen at 1.06% versus 7.00%
Net profit expected to be seen at Rs -95 crore versus Rs -8 crore
GILLETTE YoY
Revenue expected at Rs 729 crore versus Rs 680 crore
EBITDA expected to be seen at Rs 182 crore versus Rs 160 crore
EBITDA margin expected to be seen at 25.00% versus 23.55%
Net profit expected to be seen at Rs 123 crore versus Rs 99 crore
KEC YoY
Revenue expected at Rs 6986 crore versus Rs 6164 crore
EBITDA expected to be seen at Rs 557 crore versus Rs 388 crore
EBITDA margin expected to be seen at 7.98% versus 6.29%
Net profit expected to be seen at Rs 262 crore versus Rs 151 crore
SUMICHEM YoY
Revenue expected at Rs 722 crore versus Rs 674 crore
EBITDA expected to be seen at Rs 141 crore versus Rs 101 crore
EBITDA margin expected to be seen at 19.55% versus 15.02%
Net profit expected to be seen at Rs 116 crore versus Rs 109 crore
| 27.05.2025: | AFCOM, AJAXENGG, AMNPLST, BBOX,BDL, BLACKBUCK, BOSCHLTD, CARRARO, DCXINDIA, DECCANCE, DEEDEV, DIACABS, DYNAMATECH, EIDPARRY, ELITECON, ENTERO, EPACK, ESABINDIA, FAIRCHEMOR, FLUOROCHEM, GALAPREC, GATEWAY, GOODYEAR, HEXATRADEX, HINDCOPPER, INDPRUD, ITI, JKLAKSHMI, JTLIND, KICL, LICI, MEDPLUS, MINDACORP, MUFIN, NAUKRI, NIBE, NMDC, NPST, NSLNISP, OAL, ORIRAIL, PFOCUS, PGHH, PRECAM, QPOWER,RCF, REDTAPE, RELTD, RISHABH, RML, ROHLTD, ROSSTECH, RTNINDIA, SABTNL, SANSERA, SEAMECLTD, SHRIRAMPPS, SIMPLEXINF, SKYGOLD, SPAL, SUNFLAG, SUPRIYA, SURAJEST, TECHNOE, TGVSL, TIMETECHNO, TRIVENI, TTKPRESTIG, TVSSRICHAK, UNIMECH, UNIPARTS, V2RETAIL, ZSARACOM |
BDL YoY
Revenue expected at Rs 1624 crore versus Rs 854 crore
EBITDA expected to be seen at Rs 457 crore versus Rs 316 crore
EBITDA margin expected to be seen at 28.16% versus 37.04%
Net profit expected to be seen at Rs 355 crore versus Rs 288 crore
BOSCHLTD YoY
Revenue expected at Rs 4497 crore versus Rs 4233 crore
EBITDA expected to be seen at Rs 577 crore versus Rs 438 crore
EBITDA margin expected to be seen at 12.84% versus 10.36%
Net profit expected to be seen at Rs 532 crore versus Rs 564 crore
FLUOROCHEM YoY
Revenue expected at Rs 1244 crore versus Rs 1133 crore
EBITDA expected to be seen at Rs 331 crore versus Rs 229 crore
EBITDA margin expected to be seen at 26.60% versus 20.21%
Net profit expected to be seen at Rs 187 crore versus Rs 101 crore
LICI QoQ
APE expected at Rs 18395 crore versus Rs 9950 crore
EBIT expected to be seen at Rs 11910 crore versus Rs 11036 crore
EBIT margin expected to be seen at 7.55% versus 5.43%
Net profit expected to be seen at Rs 14800 crore versus Rs 11008 crore
NAUKRI YoY
Revenue expected at Rs 710 crore versus Rs 608 crore
EBITDA expected to be seen at Rs 296 crore versus Rs 246 crore
EBITDA margin expected to be seen at 41.66% versus 40.59%
Net profit expected to be seen at Rs 265 crore versus Rs 223 crore
NMDC YoY
Revenue expected at Rs 6679 crore versus Rs 6489 crore
EBITDA expected to be seen at Rs 2294 crore versus Rs 2101 crore
EBITDA margin expected to be seen at 34.35% versus 32.39%
Net profit expected to be seen at Rs 1839 crore versus Rs 1442 crore
PGHH YoY
Revenue expected at Rs 1087 crore versus Rs 931 crore
EBITDA expected to be seen at Rs 276 crore versus Rs 118 crore
EBITDA margin expected to be seen at 25.46% versus 12.70%
Net profit expected to be seen at Rs 204 crore versus Rs 81 crore
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
